Clinical Trial Update: Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study assessing more frequent administration of lower-dose chemotherapy with bevacizumab (Avastin) for advanced non-squamous non-small cell lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-05-24